Stock analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the software maker’s stock.
Veradigm Price Performance
NASDAQ MDRX opened at $9.45 on Friday. Veradigm has a 52-week low of $5.01 and a 52-week high of $11.80. The business has a 50 day simple moving average of $9.99 and a 200 day simple moving average of $9.73.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC bought a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Insider Trading – What You Need to Know
- Top 3 Investment Themes to Watch for in 2025
- How to Use the MarketBeat Excel Dividend Calculator
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What is the Euro STOXX 50 Index?
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
